|
LithobidDrug - Lithobid The trade name of the product as shown on the labeling.
Dosage -
TABLET, EXTENDED RELEASE; ORAL
Active Ingredient(s) -
Lithium Carbonate
Strength -
300MG
Applicant -
JDS PHARMS
New Drug Application (NDA) Number -
018027
Product Number -
001
Therapeutic Equivalence (TE) Code -
AB
Approval Date -
Approved Prior to Jan 1, 1982
Reference Listed Drug (RLD) -
Yes
Type -
RX
Applicant Full Name -
Jds Pharmaceuticals Llc
Lithobid
Lithonate 300mg Capsule; Oral
Eskalith Cr 450mg Tablet, Extended Release; Oral Lithium Carbonate 300mg Tablet, Extended Release; Oral Lithium Carbonate 300mg Tablet, Extended Release; Oral Lithium Carbonate 450mg Tablet, Extended Release; Oral Lithium Carbonate 300mg Tablet, Extended Release; Oral Lithium Carbonate 450mg Tablet, Extended Release; Oral Lithium Carbonate 450mg Tablet, Extended Release; Oral Lithobid 300mg Tablet, Extended Release; Oral Lithium Carbonate 300mg Capsule; Oral NewDrugInformation |